JPH0240644B2 - - Google Patents

Info

Publication number
JPH0240644B2
JPH0240644B2 JP54054283A JP5428379A JPH0240644B2 JP H0240644 B2 JPH0240644 B2 JP H0240644B2 JP 54054283 A JP54054283 A JP 54054283A JP 5428379 A JP5428379 A JP 5428379A JP H0240644 B2 JPH0240644 B2 JP H0240644B2
Authority
JP
Japan
Prior art keywords
liposome
liposomes
active substance
present
wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP54054283A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55153713A (en
Inventor
Takatoshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP5428379A priority Critical patent/JPS55153713A/ja
Priority to CA000351077A priority patent/CA1143656A/en
Priority to GB8014793A priority patent/GB2050287B/en
Priority to DE19803016976 priority patent/DE3016976A1/de
Priority to FR8009985A priority patent/FR2455458A1/fr
Publication of JPS55153713A publication Critical patent/JPS55153713A/ja
Publication of JPH0240644B2 publication Critical patent/JPH0240644B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP5428379A 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance Granted JPS55153713A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP5428379A JPS55153713A (en) 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance
CA000351077A CA1143656A (en) 1979-05-02 1980-05-01 Liposome including active substance
GB8014793A GB2050287B (en) 1979-05-02 1980-05-02 Liposomes containing physiologically active substances
DE19803016976 DE3016976A1 (de) 1979-05-02 1980-05-02 Liposom mit einem gehalt an einer aktiven substanz und verfahren zu dessen herstellung
FR8009985A FR2455458A1 (fr) 1979-05-02 1980-05-05 Liposomes contenant une substance active, notamment un principe actif de medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5428379A JPS55153713A (en) 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance

Publications (2)

Publication Number Publication Date
JPS55153713A JPS55153713A (en) 1980-11-29
JPH0240644B2 true JPH0240644B2 (en:Method) 1990-09-12

Family

ID=12966226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5428379A Granted JPS55153713A (en) 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance

Country Status (5)

Country Link
JP (1) JPS55153713A (en:Method)
CA (1) CA1143656A (en:Method)
DE (1) DE3016976A1 (en:Method)
FR (1) FR2455458A1 (en:Method)
GB (1) GB2050287B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657741U (ja) * 1993-01-22 1994-08-12 株式会社村上開明堂 監視機能付きミラー装置

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
JPS60152410A (ja) * 1984-01-23 1985-08-10 Pola Chem Ind Inc 皮膚外用剤
FR2562421B1 (fr) * 1984-04-09 1989-02-17 Sandoz Sa Perfectionnements a la therapie par l'interleukine
JPS61100518A (ja) * 1984-10-22 1986-05-19 Ono Pharmaceut Co Ltd ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
GB8428222D0 (en) * 1984-11-08 1984-12-19 Bentall R H C Quantifying interaction of induced currents
US5023087A (en) * 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
ATE115403T1 (de) * 1987-01-27 1994-12-15 Vestar Inc Aus phospholipiden bestehende darreichungsform für wasserunlösliche wirksubstanzen.
US5723147A (en) * 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5811118A (en) * 1987-05-22 1998-09-22 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
AU617678B2 (en) * 1987-05-22 1991-12-05 Liposome Company, Inc., The Prostaglandin-lipid formulations
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
US5807572A (en) * 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
FR2649610B1 (fr) * 1989-07-13 1994-06-03 Dior Christian Parfums Composition cosmetique ou pharmaceutique et notamment dermatologique contenant de l'ampc ou ses derives en liposomes
DE4005711C1 (en:Method) * 1990-02-23 1991-06-13 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
DE4108902A1 (de) * 1990-08-06 1992-02-13 Nattermann A & Cie Wasserhaltiges liposomensystem
DE4107152C2 (de) * 1991-03-06 1994-03-24 Gregor Cevc Präparate zur nichtinvasiven Verabreichung von Antidiabetica
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
DE4107153A1 (de) * 1991-03-06 1992-09-10 Gregor Cevc Praeparat zur wirkstoffapplikation in kleinsttroepfchenform
FR2685868B1 (fr) * 1992-01-03 1995-06-23 Corbiere Jerome Nouvelles preparations pharmaceutiques a base de peptides pour la voie generale.
WO1995001163A1 (fr) * 1992-01-03 1995-01-12 Corbiere Jerome Nouvelles preparations pharmaceutiques a base de peptides pour la voie generale
AU3442093A (en) * 1992-01-16 1993-08-03 Argus Pharmaceuticals, Inc. Formulation and use of carotenoids in treatment of cancer
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5989587A (en) * 1992-10-23 1999-11-23 National Research Council Of Canada Formation of stable liposomes from lipid extracts of archaeobacteria (archaeu)
US5455044A (en) * 1993-05-14 1995-10-03 Depotech Corporation Method for treating neurological disorders
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
IL107471A (en) * 1993-11-02 1997-09-30 Yissum Res Dev Co Pharmaceutical preparation comprising a self- emulsifying formulation and process for its production
JP3002702B2 (ja) * 1993-11-16 2000-01-24 スカイファーム インコーポレーテッド 活性物質の制御放出を有する小胞
US5840328A (en) * 1994-01-11 1998-11-24 The Liposome Company, Inc. Treatment using arachidonic acid metabolite and particulate formulations
AU3361595A (en) * 1994-08-08 1996-03-07 Argus Pharmaceuticals, Inc. Formulation and use of carotenoids in treatment of cancer
US5993850A (en) * 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5997899A (en) 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
CA2296056A1 (en) * 1997-07-10 1999-01-21 Keith Baker Methods for universally distributing therapeutic agents to the brain
US6306432B1 (en) 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
ATE535232T1 (de) 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
JP4575592B2 (ja) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
ES2226203T3 (es) 1998-12-23 2005-03-16 Idea Ag Formulacion mejorada para aplicacion topica no invasiva.
SI1031346T1 (en) 1999-01-27 2002-08-31 Idea Ag Noninvasive vaccination through the skin
SI1031347T1 (en) 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
US20030068361A1 (en) * 2001-10-09 2003-04-10 Rimona Margalit Liposome-encapsulated insulin formulations
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
JPWO2005053643A1 (ja) * 2003-12-01 2007-06-28 三菱ウェルファーマ株式会社 リポソーム
EP2585046A4 (en) * 2010-06-23 2013-11-06 Brightside Innovations Inc LECITHINTRÄGERVESIKEL AND METHOD FOR THE PRODUCTION THEREOF
JP2015514683A (ja) * 2012-02-16 2015-05-21 ブライトサイド イノベーションズ，インコーポレイティド 食品性栄養組成物および使用方法
JP6661319B2 (ja) * 2015-09-28 2020-03-11 小林製薬株式会社 リポソーム
RU2746414C1 (ru) * 2017-05-23 2021-04-13 ТиСиАй КО., ЛТД. Эмульгированная липосомальная композиция и способ ее получения
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060030A (en) * 1960-04-04 1962-10-23 Carl F Obenauf Lecithinated product
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
CA1119955A (en) * 1978-04-14 1982-03-16 Little (Arthur D.), Inc. Xenobiotic delivery vehicles, method of forming them and method of using them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657741U (ja) * 1993-01-22 1994-08-12 株式会社村上開明堂 監視機能付きミラー装置

Also Published As

Publication number Publication date
FR2455458A1 (fr) 1980-11-28
JPS55153713A (en) 1980-11-29
GB2050287B (en) 1983-04-20
DE3016976A1 (de) 1980-11-13
GB2050287A (en) 1981-01-07
CA1143656A (en) 1983-03-29
FR2455458B1 (en:Method) 1983-04-15

Similar Documents

Publication Publication Date Title
JPH0240644B2 (en:Method)
CN103764127B (zh) 药理学活性物质的持续释放脂质预浓缩物和含有其的药物组合物
CA2178602C (en) Microcapsules, method of making and their use
CN102274183B (zh) 一种多囊脂质体制备方法和应用
KR910004580B1 (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
RU2493874C2 (ru) Транслегочная липосома для регулирования доставки лекарственного средства
JPH0665650B2 (ja) インタ−リユ−キン療法に関する改良
JPS6354684B2 (en:Method)
WO2010083778A1 (zh) 注射用肺靶向脂质体药物组合物
CN107427482A (zh) 凝血酸的多囊脂质体制剂
DK165220B (da) Liposomsammensaetninger indeholdende syntetiske phospholipider og et farmaceutisk aktivt stof samt deres fremstilling og phospholipidblanding til fremstilling af sammensaetningerne
JPH0751496B2 (ja) リポソ−ムの製造法
AU583272B2 (en) Coacervate system synthetic whole blood substitute
JPH0768130B2 (ja) 微粒子化薬剤
JPH0395118A (ja) プロスタグランジン含有脂肪小体製剤
JPWO2003015753A1 (ja) リポソーム製剤
US4853370A (en) Substitute for human blood and a method of making the same
JPS59222410A (ja) 薬物保持リポソ−ム製剤
JP4444385B2 (ja) リポソーム用時調製用キット
JPH0741432A (ja) 新規な徐放性医薬品組成物
JPH04356421A (ja) プロスタグランジン類含有脂肪小体組成物
CN112773776B (zh) 一种载药纳米粒体系
JPS63221837A (ja) 脂質膜構造体
JP2911550B2 (ja) リポソーム製剤
CN102274182A (zh) 一种含有艾塞那肽的多囊脂质体及其制备方法和应用